564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agents

白细胞介素12 体内 效力 肿瘤微环境 材料科学 癌症研究 免疫系统 体外 免疫学 生物 细胞毒性T细胞 生物化学 生物技术
作者
Matthew J. Bernett,Rajat Varma,Ke Liu,Christine Bonzon,Rumana Rashid,Nicole Rodriguez,Nargess Hassanzadeh‐Kiabi,Connie Ardila,Seung Y. Chu,Umesh Muchhal,John R. Desjarlais
标识
DOI:10.1136/jitc-2020-sitc2020.0564
摘要

Background

Interleukin-12 (IL12) is a proinflammatory cytokine produced by activated antigen-presenting cells that induces differentiation of Th1 cells and increased proliferation and cytotoxicity of T and NK cells. Stimulation of these cells by IL12 leads to production of high levels of IFNγ. These immune-stimulating aspects of IL12 may help to establish an inflammatory tumor microenvironment critical for anti-tumor responses. Preclinical studies in mice revealed that native IL12 can dramatically shrink syngeneic tumors, however clinical studies in humans resulted in severe toxicity and a small therapeutic window, limiting response rates. Prior work at Xencor demonstrated that reduced-potency IL15/IL15Rα-Fc fusion proteins exhibited superior pharmacokinetics, pharmacodynamics, and safety in non-human primates through reduction of receptor-mediated clearance. Applying similar principles to IL12, we created IL12 heterodimeric Fc-fusions (IL12-Fc) with reduced potency to improve tolerability, slow receptor-mediated clearance, and extend half-life.

Methods

IL12 is a heterodimeric protein consisting of two subunits, so we engineered IL12-Fc fusions by fusing the IL12p35 subunit to one side of a heterodimeric (and inactive) Fc domain, and the IL12p40 subunit to the other side. These Fc-fusions were tuned for optimal activity by introducing amino acid substitutions at putative receptor-interface positions and screening for reductions of in vitro potency. In vitro activity was assessed on human PBMCs by measuring signaling in a STAT4 phosphorylation assay and IFNγ production in a mixed-lymphocyte reaction (MLR). In vivo anti-tumor activity was assessed by engrafting MCF-7 cells into PBMC engrafted NSG MHC class I and II double-knockout mice and by measuring tumor volume, lymphocyte activation/proliferation, and IFNγ production over time.

Results

IL12-Fc were produced with good yield and purity. An IL12-Fc potency series was created, and variants had up to a 10,000-fold reduction in STAT4 signaling potency and IFNγ production in an MLR assay compared to native IL12-Fc. Anti-tumor activity in the huPBMC-MCF7 model was achieved with potency-reduced IL12-Fc as a single-agent and in combination with anti-PD1, with weaker variants maintaining anti-tumor activity at higher dose levels. Analysis of peripheral lymphocytes indicated increased numbers of T and NK cells as well as activation of CD8+ T cells, as evidenced by upregulation of CD25. Increased expression of immune checkpoints including PD1 was also observed. Analysis of serum indicated up to 200-fold increases in IFNγ levels.

Conclusions

Combined, these data indicate that potency-reduced IL12-Fc retain strong anti-tumor activity, while potentially overcoming safety and tolerability issues related to small therapeutic index associated with recombinant native IL12 or IL12-Fc agents.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
追寻的寻真完成签到,获得积分10
刚刚
追寻海云完成签到,获得积分10
1秒前
caffeine应助笃定采纳,获得10
1秒前
科研通AI2S应助眼睛大怀曼采纳,获得10
1秒前
最佳损友完成签到,获得积分10
1秒前
冷傲的鞋子完成签到,获得积分10
2秒前
852应助jaslek采纳,获得10
2秒前
小马甲应助chrysan采纳,获得10
3秒前
袁月辉发布了新的文献求助10
3秒前
碧蓝代秋完成签到,获得积分10
3秒前
skkk完成签到,获得积分10
4秒前
辛勤的灵薇完成签到,获得积分10
4秒前
花痴的手套完成签到 ,获得积分10
4秒前
5秒前
丘比特应助可爱静静采纳,获得10
6秒前
白马二师兄完成签到,获得积分10
8秒前
QIN完成签到,获得积分10
9秒前
10秒前
OVERSEER完成签到,获得积分10
13秒前
zj完成签到,获得积分10
13秒前
哈罗完成签到,获得积分10
13秒前
123发布了新的文献求助10
13秒前
宁静致远完成签到,获得积分10
13秒前
hanger完成签到,获得积分10
15秒前
腼腆的老虎完成签到,获得积分10
16秒前
憨憨完成签到 ,获得积分10
16秒前
bkagyin应助si采纳,获得10
17秒前
18秒前
18秒前
眼睛大怀曼完成签到,获得积分10
19秒前
叶子完成签到 ,获得积分10
20秒前
可爱静静完成签到,获得积分20
22秒前
思源应助心有林夕采纳,获得10
23秒前
1123432412发布了新的文献求助10
23秒前
chrysan发布了新的文献求助10
24秒前
小菜鸟完成签到 ,获得积分10
24秒前
谦让成协完成签到,获得积分10
24秒前
林洁佳完成签到,获得积分10
25秒前
55完成签到,获得积分10
25秒前
25秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Very-high-order BVD Schemes Using β-variable THINC Method 568
探索化学的奥秘:电子结构方法 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137174
求助须知:如何正确求助?哪些是违规求助? 2788239
关于积分的说明 7785062
捐赠科研通 2444183
什么是DOI,文献DOI怎么找? 1299854
科研通“疑难数据库(出版商)”最低求助积分说明 625586
版权声明 601011